Resource Logo

Pulmonary malignancies in the immunocompromised patient.


Respiration. 1999;66(4):289-309. Unique Identifier : AIDSLINE

Clinicians should be familiar with immunodeficiency-related malignancies, as their incidence is expected to increase further with the rise in the number and survival of immunocompromised patients. The most common malignancies affecting the lungs in those patients are Kaposi's sarcoma, non-Hodgkin's lymphoma and, to a far less extent, Hodgkin's disease and bronchogenic carcinoma. However, their relative frequency depends on the types of immune deficiency, including those due to congenital disorders, AIDS and drug treatments. This review will summarize epidemiological data on the frequency of immmunodeficiency-related malignancies, recent advances on their pathogenesis and current approaches to their diagnosis and treatment in the various immunosuppressed groups.

JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Acquired Immunodeficiency Syndrome/IMMUNOLOGY Carcinoma, Bronchogenic/IMMUNOLOGY Hodgkin Disease/IMMUNOLOGY Human *Immunocompromised Host Immunosuppression Lung Neoplasms/*IMMUNOLOGY Lymphoma, AIDS-Related/IMMUNOLOGY Lymphoma, Non-Hodgkin/IMMUNOLOGY Sarcoma, Kaposi/IMMUNOLOGY Transplantation Immunology


Information in this article was accurate in December 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.